vs

Side-by-side financial comparison of INSTEEL INDUSTRIES INC (IIIN) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

INSTEEL INDUSTRIES INC is the larger business by last-quarter revenue ($159.9M vs $83.1M, roughly 1.9× PROCEPT BioRobotics Corp). INSTEEL INDUSTRIES INC runs the higher net margin — 4.7% vs -38.1%, a 42.8% gap on every dollar of revenue. On growth, INSTEEL INDUSTRIES INC posted the faster year-over-year revenue change (23.3% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 12.0%).

Insteel Industries Inc is a leading U.S. manufacturer of steel reinforcing products including welded wire reinforcement and steel fibers. It primarily serves non-residential construction, infrastructure, and precast concrete segments across North America, delivering high-performance reinforcement solutions for various construction projects.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

IIIN vs PRCT — Head-to-Head

Bigger by revenue
IIIN
IIIN
1.9× larger
IIIN
$159.9M
$83.1M
PRCT
Growing faster (revenue YoY)
IIIN
IIIN
+3.1% gap
IIIN
23.3%
20.2%
PRCT
Higher net margin
IIIN
IIIN
42.8% more per $
IIIN
4.7%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
12.0%
IIIN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
IIIN
IIIN
PRCT
PRCT
Revenue
$159.9M
$83.1M
Net Profit
$7.6M
$-31.6M
Gross Margin
11.3%
64.9%
Operating Margin
6.0%
-4.1%
Net Margin
4.7%
-38.1%
Revenue YoY
23.3%
20.2%
Net Profit YoY
602.4%
-27.9%
EPS (diluted)
$0.39
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IIIN
IIIN
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$159.9M
$76.4M
Q3 25
$177.4M
$83.3M
Q2 25
$179.9M
$79.2M
Q1 25
$160.7M
$69.2M
Q4 24
$129.7M
$68.2M
Q3 24
$134.3M
$58.4M
Q2 24
$145.8M
$53.4M
Net Profit
IIIN
IIIN
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$7.6M
$-29.8M
Q3 25
$14.6M
$-21.4M
Q2 25
$15.2M
$-19.6M
Q1 25
$10.2M
$-24.7M
Q4 24
$1.1M
$-18.9M
Q3 24
$4.7M
$-21.0M
Q2 24
$6.6M
$-25.6M
Gross Margin
IIIN
IIIN
PRCT
PRCT
Q1 26
64.9%
Q4 25
11.3%
60.6%
Q3 25
16.1%
64.8%
Q2 25
17.1%
65.4%
Q1 25
15.3%
63.9%
Q4 24
7.3%
64.0%
Q3 24
9.1%
63.2%
Q2 24
10.6%
59.0%
Operating Margin
IIIN
IIIN
PRCT
PRCT
Q1 26
-4.1%
Q4 25
6.0%
-40.6%
Q3 25
10.8%
-27.8%
Q2 25
11.0%
-28.0%
Q1 25
8.3%
-39.7%
Q4 24
1.1%
-28.9%
Q3 24
4.5%
-38.4%
Q2 24
6.0%
-50.3%
Net Margin
IIIN
IIIN
PRCT
PRCT
Q1 26
-38.1%
Q4 25
4.7%
-39.1%
Q3 25
8.2%
-25.7%
Q2 25
8.4%
-24.7%
Q1 25
6.4%
-35.8%
Q4 24
0.8%
-27.6%
Q3 24
3.5%
-35.9%
Q2 24
4.5%
-48.0%
EPS (diluted)
IIIN
IIIN
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.39
$-0.54
Q3 25
$0.74
$-0.38
Q2 25
$0.78
$-0.35
Q1 25
$0.52
$-0.45
Q4 24
$0.06
$-0.34
Q3 24
$0.24
$-0.40
Q2 24
$0.34
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IIIN
IIIN
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$15.6M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$358.8M
$347.7M
Total Assets
$456.1M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IIIN
IIIN
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$15.6M
$286.5M
Q3 25
$38.6M
$294.3M
Q2 25
$53.7M
$302.7M
Q1 25
$28.4M
$316.2M
Q4 24
$36.0M
$333.7M
Q3 24
$111.5M
$196.8M
Q2 24
$97.7M
$214.1M
Total Debt
IIIN
IIIN
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
IIIN
IIIN
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$358.8M
$365.9M
Q3 25
$371.5M
$380.3M
Q2 25
$356.2M
$385.8M
Q1 25
$341.4M
$389.2M
Q4 24
$331.6M
$402.2M
Q3 24
$350.9M
$241.2M
Q2 24
$346.0M
$251.8M
Total Assets
IIIN
IIIN
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$456.1M
$508.1M
Q3 25
$462.6M
$511.5M
Q2 25
$471.9M
$513.1M
Q1 25
$421.9M
$519.4M
Q4 24
$404.7M
$534.0M
Q3 24
$422.6M
$374.1M
Q2 24
$414.6M
$374.4M
Debt / Equity
IIIN
IIIN
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IIIN
IIIN
PRCT
PRCT
Operating Cash FlowLast quarter
$-701.0K
Free Cash FlowOCF − Capex
$-2.2M
FCF MarginFCF / Revenue
-1.4%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
-0.09×
TTM Free Cash FlowTrailing 4 quarters
$439.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IIIN
IIIN
PRCT
PRCT
Q1 26
Q4 25
$-701.0K
$-10.3M
Q3 25
$-17.0M
$-6.6M
Q2 25
$28.5M
$-15.0M
Q1 25
$-3.3M
$-17.0M
Q4 24
$19.0M
$-32.4M
Q3 24
$16.2M
$-18.8M
Q2 24
$18.8M
$-15.7M
Free Cash Flow
IIIN
IIIN
PRCT
PRCT
Q1 26
Q4 25
$-2.2M
$-12.2M
Q3 25
$-18.7M
$-9.5M
Q2 25
$26.9M
$-17.8M
Q1 25
$-5.5M
$-18.8M
Q4 24
$16.3M
$-33.6M
Q3 24
$14.5M
$-19.0M
Q2 24
$15.5M
$-16.8M
FCF Margin
IIIN
IIIN
PRCT
PRCT
Q1 26
Q4 25
-1.4%
-15.9%
Q3 25
-10.6%
-11.4%
Q2 25
15.0%
-22.5%
Q1 25
-3.5%
-27.2%
Q4 24
12.6%
-49.2%
Q3 24
10.8%
-32.6%
Q2 24
10.7%
-31.4%
Capex Intensity
IIIN
IIIN
PRCT
PRCT
Q1 26
Q4 25
0.9%
2.4%
Q3 25
1.0%
3.4%
Q2 25
0.9%
3.5%
Q1 25
1.4%
2.7%
Q4 24
2.1%
1.7%
Q3 24
1.3%
0.4%
Q2 24
2.2%
2.0%
Cash Conversion
IIIN
IIIN
PRCT
PRCT
Q1 26
Q4 25
-0.09×
Q3 25
-1.17×
Q2 25
1.88×
Q1 25
-0.32×
Q4 24
17.56×
Q3 24
3.48×
Q2 24
2.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IIIN
IIIN

Welded Wire Reinforcement$108.4M68%
PC Strand$51.6M32%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons